Vistagen meets ICH safety exposure standards for fasedienol trials
Go back to Vistagen meets ICH safety exposure standards for fasedienol trials| (NASDAQ: VTGN) | Delayed: 0.64 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.64 | 52 Week High | $4.60 | |||
| Open | $0.64 | 52 Week Low | $2.81 | |||
| Day High | $0.64 | P/E | N/A | |||
| Day Low | $0.64 | EPS | $0.00 | |||
| Volume | 2,369 | |||||

